Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Advent-Harrington Impact Fund Lp investment portfolio

Advent-Harrington Impact Fund Lp has made numerous investments in companies such as Beacon Therapeutics Holdings, Curve Therapeutics, and Cenentry Biosciences within the Healthcare & Life Sciences sector.

vc
Portfolio
4
Team
0

Portfolio (4)

CompanySectorCitySourceLast confirmed on
Beacon Therapeutics Holdings Limited
Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders.
Healthcare & Life SciencesLondonConfirmed2025-08-17
Cenentry Biosciences LimitedHealthcare & Life SciencesCambridgeConfirmed2026-03-25

Sign up to see the full portfolio

+2 more companies

Sign up

Shareholding changes (5)

Advent-Harrington Impact Fund Lp's positions across portfolio companies
2026
  • 04-22ConvertedEpitopea Limited
    • ORDINARY 370,493 → 0
    • SERIES A-1 SEED PREFERRED 617,487 → 0
    • SERIES A-2 SEED PREFERRED 699,832 → 0
    • ORDINARY 0.0001 GBP 0 → 370,493
    • SERIES A-1 SEED PREFERRED 0.0001 GBP 0 → 617,487
    • SERIES A-2 SEED PREFERRED 0.0001 GBP 0 → 699,832
2025

Sign up free to see when this investor has bought or sold shares.

+3 more changes

Sign up